Danaher’s second-quarter earnings exceeded expectations, with revenue up 3.5% to $5.94 billion and adjusted EPS at $1.80. Despite challenges in China, all operating segments showed strong performance, though cash flow results were slightly below expectations. The company remains confident in its cost-saving efforts and reiterated its full-year guidance for 3% revenue growth and adjusted EPS of $7.70 to $7.80. Biotechnology thrived with high-single-digit growth in bioprocessing and positive order trends, supporting expectations for high-single-digit growth in the second half. Monoclonal antibodies remained a key area of investment, with a healthy pipeline of new molecules in development. In the life sciences segment, Danaher reported strong demand in clinical and applied markets globally, offset by weak demand in academic and government markets. China market showed improvement in demand due to stimulus-related funding. Diagnostics segment saw low single digit revenue growth, with Beckman Coulter Diagnostics and Cepheid driving growth in key areas like sexual health and hospital-acquired infections. (Source: CNBC)
Jim Cramer’s Charitable Trust is long on DHR and ABT. Subscribers to CNBC Investing Club receive trade alerts before Jim makes a move, with a waiting period of 45 minutes after the alert is sent. If Jim discusses a stock on TV, he waits 72 hours before executing a trade. Terms and conditions apply, no guaranteed outcomes or profits. (Source: CNBC)
Read more at CNBC
– Apple announces a $430 billion investment in US manufacturing and innovation over the next five years, creating 20,000 new jobs in the process.
– The FDA expands Pfizer’s COVID-19 vaccine emergency use authorization to include children aged 12 to 15, citing strong safety and efficacy data.
– Colonial Pipeline restarts operations after a cyberattack forced a shutdown, causing gas shortages and price spikes across the East Coast.
– Elon Musk tweets that Tesla will no longer accept Bitcoin as payment due to environmental concerns, causing the cryptocurrency to plummet in value.
– Amazon announces plans to buy MGM Studios for $8.45 billion, expanding its content library with iconic franchises like James Bond and Rocky.: Danaher’s imperfect quarter is good enough for us to stay the course